Retractable Technologies, Inc. (RVP) Stock Score, Valuation & Financial Research
Retractable Technologies, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 31/100.
Quick answer for RVP
Retractable Technologies, Inc. currently has a Wall Street Score of 31/100. The stored market price is $0.68. Its financial score is 25/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Retractable Technologies, Inc. does
Retractable Technologies, Inc. is a medical device company focused on the innovation, production, and sale of secure medical instruments, predominantly syringes, for the healthcare sector. Their reach extends across the United States, the broader North and South American continents, and other international territories. The company's diverse product range includes a variety of safety-engineered items such as VanishPoint insulin, tuberculin, and allergy antigen syringes, as well as Patient Safe syringes and Luer Caps. They also offer small diameter tube adapters, blood collection tube holders, allergy trays, and IV safety catheters. Further offerings feature VanishPoint blood collection sets, EasyPoint needles, and VanishPoint autodisable syringes. Distribution of these products occurs through a combination of general and specialized distributors, international partners, and a dedicated di
RVP financial snapshot
- Wall Street Score:
- 31/100
- Current price:
- $0.68
- Market capitalization:
- $20.4M
- Revenue:
- $33.9M
- Net income:
- $-3.4M
- Free cash flow:
- $-7.6M
- Cash:
- $2.6M
- Total debt:
- $716K
- EPS:
- -0.12
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 16/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $-7.6M, showing cash burn in the current stored period.
- The balance sheet shows $2.6M of cash versus $716K of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research RVP
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.